Long-Term Safety Profile of Secukinumab Analysis

Rheumnow Podcast - Un pódcast de Dr. Cush

Podcast artwork

Long-Term Safety Profile of Secukinumab Analysis of Malignancies Up to 5 Years of Exposure Across Indications Sponsored by Novartis Medical Affairs

Visit the podcast's native language site